Reischl U
Institute of Medical Microbiology and Hygiene, University of Regensburg, Franz-Josef-Straubeta-Allee 11, 93053 Regensburg, Germany.
Front Biosci. 1996 Aug 1;1:e72-7. doi: 10.2741/a145.
The basis for effective treatment and cure of a patient is the rapid diagnosis of the disease and its causative agent, which is founded on the analysis of the clinical symptoms coupled with laboratory tests. As we approach the 21st century, clinicians are becoming increasingly able to diagnose and treat diseases at the molecular level. The rapid development of new methods and techniques in the area of molecular biology has gained new insights into the genetic and structural features of a considerable number of human pathogens. These results obtained by intensive basic research are currently leading to improved diagnostic procedures. Basically, there are four different possibilities for laboratory diagnosis of infections: 1. direct detection of the pathogens (e.g., microscopy and/or culture), 2. detection of protein components of the pathogens with the help of specific antibodies (e.g., antigen capture ELISA) 3. IgA-, IgM- and IgG-specific detection of antibodies directed against a given pathogen and changes in their corresponding titer, and as the most sensitive method, 4. specific detection of nucleic acids (e.g., PCR) of the pathogens. Here, the human immunodeficiency virus (HIV) and Mycobacterium tuberculosis are serving as examples to review the recent developments as well as the future perspectives in molecular biology-based laboratory diagnosis.
有效治疗和治愈患者的基础是对疾病及其病原体进行快速诊断,这基于对临床症状的分析以及实验室检测。随着我们迈向21世纪,临床医生越来越能够在分子水平上诊断和治疗疾病。分子生物学领域新方法和技术的迅速发展,使人们对大量人类病原体的遗传和结构特征有了新的认识。通过深入基础研究获得的这些结果目前正促使诊断程序得到改进。基本上,感染的实验室诊断有四种不同的方法:1. 直接检测病原体(例如显微镜检查和/或培养);2. 借助特异性抗体检测病原体的蛋白质成分(例如抗原捕获酶联免疫吸附测定);3. 针对特定病原体的IgA、IgM和IgG特异性抗体检测及其相应滴度的变化,作为最敏感的方法,4. 病原体核酸的特异性检测(例如聚合酶链反应)。在此,以人类免疫缺陷病毒(HIV)和结核分枝杆菌为例,回顾基于分子生物学的实验室诊断的最新进展以及未来前景。